Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity

International Journal of Obesity

Volumn 40, Issue 4, 2016, Pages 675-684

  Mulder, P ^a,b   Morrison, M C ^a   Wielinga, P Y ^a   Van Duyvenvoorde, W ^a   Kooistra, T ^a   Kleemann, R ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; LEPTIN; LIPID; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL AGGREGATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDIDYMAL TISSUE; EPIDIDYMIS FAT; GENE EXPRESSION; INFLAMMATORY CELL; LIPID DIET; LIPID STORAGE; LIPIDOMICS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SHAM PROCEDURE; SUBCUTANEOUS TISSUE; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; INFLAMMATION; LIVER; MALE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ADIPOSE TISSUE, WHITE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATION; LIVER; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84949255288     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.226     Document Type: Article

References (39)

1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10: 686-690.
2. de Alwis NM, Day CP. Non-Alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48: S104-S112.
3. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37: 909-916.
4. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-171.
5. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48: 449-457.
6. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006; 55: 1554-1561.
7. Tordjman J, Poitou C, Hugol D, Bouillot JL, Basdevant A, Bedossa P et al. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol 2009; 51: 354-362.
8. Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M et al. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). J Physiol Pharmacol 2009; 60: 71-75.
9. Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F et al. Serum adipokine levels predictive of liver injury in non-Alcoholic fatty liver disease. Liver Int 2009; 29: 1431-1438.
10. Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 2001; 46: 2347-2352.
11. Liang W, Tonini G, Mulder P, Kelder T, van Erk M, van den Hoek AM et al. Coordinated and interactive expression of genes of lipid metabolism and inflammation in adipose tissue and liver during metabolic overload. PLoS One 2013; 8: e75290.
12. Duval C, Thissen U, Keshtkar S, Accart B, Stienstra R, Boekschoten MV et al. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes 2010; 59: 3181-3191.
13. Tordjman J, Guerre-Millo M, Clement K. Adipose tissue inflammation and liver pathology in human obesity. Diabetes Metab 2008; 34: 658-663.
14. Suganami T, Tanaka M, Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr J 2012; 59: 849-857.
15. Caesar R, Manieri M, Kelder T, Boekschoten M, Evelo C, Muller M et al. A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS One 2010; 5: e11525.
16. Cinti S. The adipose organ: morphological perspectives of adipose tissues. Proc Nutr Soc 2001; 60: 319-328.
17. Harris RB, Hausman DB, Bartness TJ. Compensation for partial lipectomy in mice with genetic alterations of leptin and its receptor subtypes. Am J Physiol Regul Integr Comp Physiol 2002; 283: R1094-R1103.
18. Liang W, Menke AL, Driessen A, Koek GH, Lindeman JH, Stoop R et al. Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PLoS One 2014; 9: e115922.
19. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-1846.
20. Mirza MS. Obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol 2011; 2011: 592404.
21. Altintas MM, Azad A, Nayer B, Contreras G, Zaias J, Faul C et al. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 2011; 52: 480-488.
22. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, Jick Z et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007; 56: 2910-2918.
23. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-2247.
24. Lagathu C, Christodoulides C, Tan CY, Virtue S, Laudes M, Campbell M et al. Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int J Obes (Lond) 2010; 34: 1695-1705.
25. Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY et al. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol 2009; 24: 1658-1668.
26. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-An allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-349.
27. Salles J, Tardif N, Landrier JF, Mothe-Satney I, Guillet C, Boue-Vaysse C et al. TNFalpha gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-Diet mice. J Nutr Biochem 2012; 23: 1685-1693.
28. Item F, Konrad D. Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev 2012; 13: 30-39.
29. Tordjman J, Divoux A, Prifti E, Poitou C, Pelloux V, Hugol D et al. Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity. J Hepatol 2012; 56: 1152-1158.
30. Kwon EY, Shin SK, Cho YY, Jung UJ, Kim E, Park T et al. Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity. BMC Genomics 2012; 13: 450.
31. Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res 2008; 49: 1562-1568.
32. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
33. Bigornia SJ, Farb MG, Mott MM, Hess DT, Carmine B, Fiscale A et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes 2012; 2: e30.
34. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001; 34: 288-297.
35. Aleffi S, Petrai I, Bertolani C, Parola M, Colombatto S, Novo E et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005; 42: 1339-1348.
36. Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology 2014; 147: 577-594.e1.
37. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
38. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009; 50: 1827-1838.
39. Guo X, Li H, Xu H, Halim V, Zhang W, Wang H et al. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice. PLoS One 2012; 7: e39286.